Back to top
more

Apyx Medical (APYX)

(Delayed Data from NSDQ)

$1.38 USD

1.38
25,393

+0.01 (0.73%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $1.36 -0.02 (-1.45%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Earnings Preview: Apyx Medical (APYX) Q3 Earnings Expected to Decline

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nitish Marwah headshot

4 Breakout Stocks for Impressive Returns

SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.

Apyx (APYX) Moves 10.9% Higher: Will This Strength Last?

Apyx (APYX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 69.23% and 3.28%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apyx (APYX) Upgraded to Buy: What Does It Mean for the Stock?

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Medtronic's (MDT) Midas Rex Drills Completes First U.S. Surgery

Medtronic's (MDT) recent surgeries reach a milestone in the transformation of spine surgery as a result of increased accuracy and minimally invasive technique.

Illumina (ILMN) Sequencing & Microarray Sales Hurt by Pandemic

Seasonality in DTC functionality also continues to erode Illumina's (ILMN) microarray sales.

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Abbott, Myomo and Apyx Medical

BD (BDX) Gets EUA, CE Mark for New Molecular Diagnostic Test

BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.

Apyx Medical's (APYX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Apyx Medical (APYX).

Here's Why Momentum Investors Will Love Apyx Medical (APYX)

Does Apyx Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Apyx (APYX) Upgraded to Buy: Here's What You Should Know

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Apyx Medical (APYX) Reports Q3 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 18.75% and 3.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 17.65% and 71.84%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher

NanoString Technologies (NSTG) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.